A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
Honda Y, Muramatsu H, Nanjo Y, Hirabayashi S, Meguro T, Yoshida N, Kakuda H, Ozono S, Wakamatsu M, Moritake H, Yasui M, Sano H, Manabe A, Sakashita K.
Honda Y, et al.
Int J Hematol. 2022 Feb;115(2):263-268. doi: 10.1007/s12185-021-03248-x. Epub 2021 Oct 29.
Int J Hematol. 2022.
PMID: 34714526